Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

BACKGROUND: Abnormal autocrine fibroblast growth factor 19 (FGF19) production has been observed in several types of cancers, including hepatocellular carcinoma (HCC). In this study, we investigated the potential of serum FGF19 as a novel tumor marker of HCC based on a sandwich enzyme-linked immunoso...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Maeda, Takahiro, Kanzaki, Hiroaki, Chiba, Tetsuhiro, Ao, Junjie, Kanayama, Kengo, Maruta, Susumu, Kusakabe, Yuko, Saito, Tomoko, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Nakamoto, Shingo, Nakagawa, Ryo, Muroyama, Ryosuke, Kanda, Tatsuo, Maruyama, Hitoshi, Kato, Naoya
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849282/
https://ncbi.nlm.nih.gov/pubmed/31718608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6322-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items